- Research works
- 10 ▲ 672% vs 2013–17
- Citations
- 50 5.2 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 32% world 28%
Not ranked overall: KemPharm (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at KemPharm (United States)?
Ranked on the composite score, Andrew C. Barrett lead among researchers whose main affiliation is KemPharm (United States).
- 1 Andrew C. Barrett United States · #961,488 worldwide 36 citations · 16 works
Which research topics does KemPharm (United States) publish most on?
By volume in 2022–2025: Bipolar Disorder and Treatment, Treatment of Major Depression, Attention Deficit Hyperactivity Disorder and Parkinson's Disease and Spinal Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bipolar Disorder and Treatment Psychiatry and Mental health 0 works
- 2 Treatment of Major Depression Pharmacology 0 works
- 3 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 0 works
- 4 Parkinson's Disease and Spinal Disorders Neurology 0 works
- 5 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
- 6 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
- 7 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 0 works
- 8 Pain Management and Opioid Use Anesthesiology and Pain Medicine 0 works
- 9 Child Nutrition and Feeding Issues Psychiatry and Mental health 0 works
- 10 Metabolism and Genetic Disorders Clinical Biochemistry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has KemPharm (United States)'s research output changed?
Output in 2018–2022 was 672% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Celebration
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.